Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review
figureposted on 2020-11-06, 17:35 authored by Gayathri Nagaraj, Cynthia X. Ma
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
Read the peer-reviewed publication
Aromatase inhibitorsCyclin-dependent kinase 4/6 inhibitorsEndocrine therapyFulvestrantHormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancerMammalian target of rapamycin inhibitorsPhosphoinositide 3-kinase pathway inhibitorsSelective estrogen receptor degrader